Temi della conferenza The hotly anticipated mRNA-Based Therapeutics Summit is returning in-person for its second year this July and will deliver exclusive data from the movers and shakers in mRNA vaccine and therapy development. 400+ industry pioneers from the likes of Pfizer, Moderna, Sanofi, and Arcturus Therapeutics are reuniting at the world’s only end-to-end meeting focused on the development of mRNA vaccines and therapies from early basic research through to commercialization and patients in need.
